Back to search

Article

Exploring the Therapeutic Potential of Momordica charantia in Targeting Protein Kinase C Delta (PRKCD) for Type 2 Diabetes Mellitus: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations 

2025-02-05

Abstract excerpt

<title>Abstract</title> <p>Type 2 diabetes mellitus (T2DM) is a chronic condition caused by decreased insulin production and increased insulin resistance, and its prevalence has increased by 49% since 1990. Current treatments for T2DM include pharmacological agents and lifestyle modifications, but they are limited by their side effects and cost. Herbal remedies and natural products have become popular alternative...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
277997cd-d9bd-5d46-9090-2bb4ab4a740c
DOI
10.21203/rs.3.rs-5948998/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the Therapeutic Potential of Momordica charantia in Targeting Protein Kinase C Delta (PRKCD) for Type 2 Diabetes Mellitus: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics SimulationsDOI 10.21203/rs.3.rs-5948998/v1
Exploring the therapeutic potential of Rutin and Morin in Type 2 Diabetes: A transcriptomics and molecular dynamics simulation for proteinsSemantic proximity
Material Basis and Mechanisms of Action of PuRenDan in the Treatment of Type 2 Diabetes Mellitus: An Integrated Network Pharmacology and Molecular Simulation StudySemantic proximity
In-silico Network Pharmacology and Computational Modelling of Bioactive Compounds From Allium Cepa Targeting Downstream Protein Effectors in DiabetesSemantic proximity
Network pharmacology-based investigation of potential targets of Vitamin K2MK7 in treatment of diabetic neuropathySemantic proximity
Elucidating the Type 2 Diabetes Regulatory Network: Identification of EGFR as a Key Hub and Novel Drug CandidatesSemantic proximity
Elucidation of the Inhibitory Effect of Phytochemicals with Kir6.2 Wild-Type and Mutant Models Associated in Type-1 Diabetes through Molecular Docking ApproachSemantic proximity
Exploring the Anti-Diabetic Potential of Indonesian Traditional Herbal Plants with Network Pharmacology ApproachSemantic proximity
Epidermal growth factor receptor (EGFR) as a key regulator in type 2 diabetes: Drug discovery insightsSemantic proximity
Integrative Gene Target Mapping, RNA Sequencing, In Silico Molecular Docking, ADMET Profiling and Molecular Dynamics Simulation Study of Marine Derived Molecules for Type 1 Diabetes MellitusSemantic proximity
Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitusSemantic proximity
Single-Cell RNA Sequencing Analysis of Key Candidate Genes; Molecular Modeling and Docking-Based Therapeutic Molecules Exploration of Nature Derived Phytoconstituents for Type 2 Diabetes Mellitus.Semantic proximity
Network pharmacology-based strategy to investigate the molecular target and mechanism of Jiawei Linggui Zhugan decoction in the treatment of obesitySemantic proximity
Select a neighboring publication to make it the new centre.